06/10/2025 / By Olivia Cook
Autism Spectrum Disorder (ASD) affects nearly two percent of children in the United States, leaving families searching for ways to improve their children’s quality of life. A 2021 systematic review and meta-analysis published in the Journal of Personalized Medicine highlights a promising treatment: cobalamin, more commonly known as vitamin B12. This essential nutrient, crucial for brain function and overall health, may help address underlying biochemical imbalances in children with ASD.
Autism is not just a condition of social and behavioral differences – it also involves disruptions in biochemical processes, particularly methylation and redox metabolism.
Methylation is a critical function that regulates DNA activity, neurotransmitter production and detoxification. Many children with ASD show impairments in methylation, leading to deficiencies in important compounds like glutathione, the body’s main antioxidant. This can result in increased oxidative stress, which has been linked to neurological and behavioral symptoms.
Vitamin B12, particularly in its active form methylcobalamin (mB12), plays a key role in improving these processes. It helps convert homocysteine into methionine, a vital amino acid needed for proper methylation. When methylation improves, the body can better regulate brain function, cellular repair and detoxification.
Additionally, B12 enhances redox metabolism, helping to maintain the right balance between antioxidants and harmful oxidative stress. This biochemical improvement may explain why some children experience better sleep, improved communication, enhanced social interactions and reduced hyperactivity when receiving B12 therapy.
The systematic review examined 17 studies, including four double-blind, placebo-controlled trials – the gold standard in clinical research. It found that B12 treatment led to improvements in several key areas.
Children receiving B12 therapy showed better sleep patterns, fewer tantrums, improved gastrointestinal health and reduced hyperactivity. Many also demonstrated enhanced communication skills, such as better eye contact, improved written and verbal expression, and reduced repetitive speech (echolalia).
Some even developed stronger daily living skills, such as personal hygiene and social engagement. These improvements likely stem from B12’s role in balancing neurotransmitters like dopamine and serotonin, which influence behavior, mood and sleep. (Related: Unlocking the brain’s chemical code: What neurochemistry reveals about autism.)
The review found that subcutaneous (under the skin) injections of mB12 were the most commonly used and most effective method. Since many children with ASD have gastrointestinal issues that can interfere with nutrient absorption, injections ensure that B12 reaches the bloodstream and the brain more efficiently.
The most common dosing regimen in studies was 75 micrograms per kilogram of body weight per injection, given every one to three days. For example, if a child weighs 20 kilograms (around 44 pounds) and the dose is 75 micrograms/kilogram of body weight, the total dose would be 1,500 micrograms of B12 per injection.
Oral doses ranged from 500 micrograms to 1,600 micrograms per day, but their effectiveness was less consistent due to potential absorption issues.
B12 is not a single molecule – there are several forms, each with different properties and effects on the body. Understanding these differences is crucial when considering treatment options for a child with ASD.
Overall, B12 treatment was well tolerated, with most children experiencing no major side effects. Some parents reported mild reactions, such as temporary hyperactivity, irritability or trouble sleeping, but these were not significantly different from those in placebo groups.
One study noted a rare case of anemia linked to cB12, which resolved upon switching to mB12. Importantly, 78 percent of parents whose children participated in mB12 studies wanted to continue treatment after the trials ended, suggesting they observed meaningful benefits.
A separate study looked at blood cobalt levels in children receiving mB12 injections and found that levels were elevated compared to untreated children. However, these levels remained far below toxic thresholds and no adverse health effects were reported.
While the findings are promising, researchers emphasize the need for larger, placebo-controlled studies to confirm the long-term benefits of B12 treatment. Identifying biomarkers that predict which children will respond best could help refine treatment approaches. The heterogeneity of ASD means that not all children will experience the same benefits, so a more personalized approach to B12 therapy may be necessary.
Parents considering B12 therapy should work closely with their healthcare professional to determine the most appropriate form, dose and method of administration for their child. As research continues, B12 could become a valuable tool in the broader effort to enhance the quality of life for individuals with ASD.
Watch this video to learn how vitamin B12 can help your child with autism.
This video is from the Daily Videos channel on Brighteon.com.
Vitamin B12 and folic acid prevent memory loss and improve cognition as we age.
B vitamins are CRUCIAL to heart health, brain health and eye health.
Tagged Under:
#nutrition, alternative medicine, Autism spectrum disorder, brain function, brain health, cobalamin, cognition, Glutathione, goodmediicne, health science, mB12, methylation, methylcobalamin, natural cures, natural health, natural medicine, Naturopathy, nutrients, redox metabolism, research, supplements, vitamin B12
This article may contain statements that reflect the opinion of the author